Daniel Rawlings
Physician Assistant · Slc, UTNPI 1457806275
Payments from drug & device makers
Across 99 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$895
- Sanofi$544
- GSK$193
- Amgen$148
- Regeneron Healthcare Solutions, Inc.$107
- AbbVie$96
- plus $516 from 12 others
What the payments were for
- Consulting fees$171%
- Food & beverage$2,48399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $895 |
| Sanofi | 16 | $544 |
| GSK | 12 | $193 |
| Amgen | 6 | $148 |
| Regeneron Healthcare Solutions, Inc. | 2 | $107 |
| AbbVie | 1 | $96 |
| CSL Behring | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Optinose US, Inc. | 3 | $64 |
| Grifols USA, LLC | 3 | $60 |
| Kaleo, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $40 |
| Mylan Specialty L.p. | 2 | $35 |
| Biocryst US Sales Co., LLC | 2 | $29 |
| Blueprint Medicines Corporation | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $24 |
| ADMA Biomanufacturing LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,499 in reported general payments places this provider in the 85th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva RespimatTiotropium Bromide | 11 | $10,754 |
| Montelukast Sodium | 16 | $159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSpiriva Respimat | $40 | $10,75411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Slc
- Regan BrooksSlc$606K
- Keri HolyoakMidvale$438K
- Jill EricksonSalt Lake City$179K
- Vanessa Beard-ElyMurray$80K
- Natalie BeeSalt Lake City$63K
- Jasmin CharlesTaylorsville$46K
- Luke JenkinsWest Jordan$46K
- Chanise FrandsenSandy$31K
- Alexandra RoccoWashington Terrace$31K
- Jenna RhotonOgden$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.